Skip to main content

Advertisement

Log in

Safety of transsphenoidal microsurgical approach in patients with an ACTH-secreting pituitary adenoma

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

Patients affected by Cushing’s disease often have important comorbidities directly linked to hypercortisolism that might enhance the operative risk. We report the safety of transsphenoidal surgery in patients affected by Cushing’s disease as compared with patients with nonfunctioning pituitary adenoma.

Methods

We have retrospectively analyzed 142 patients with Cushing’s disease and 299 patients with nonfunctioning pituitary adenoma who underwent transsphenoidal surgery performed by a single experienced neurosurgeon between September 2007 and December 2014. For all of them, an intraoperative computerized anesthetic record for the automatic storage of data was available.

Results

The intraoperative vital parameters and the frequency of drugs administered during anesthesia were comparable between Cushing’s disease and nonfunctioning pituitary adenoma groups. The duration of surgery was similar between the two groups (41.2 ± 11.8 vs. 42.9 ± 15.6 min), while the duration of anesthesia was slightly shorter in Cushing’s disease patients (97.6 ± 18.1 min) than in nonfunctioning pituitary adenoma patients (101.6 ± 20.6 min, p = 0.04). The total perioperative mortality rate was 0.2% (0% in Cushing’s disease vs. 0.3% in nonfunctioning pituitary adenoma). Cushing’s disease patients had surgical and medical complication rates of 3.5% each, not different from those occurring in nonfunctioning pituitary adenoma. The postoperative incidence of diabetes insipidus (10.6%) and isolated hyponatremia (10.6%) in Cushing’s disease patients was significantly higher than in nonfunctioning pituitary adenoma patients (4.4 and 4.1%; p = 0.02 and p = 0.01, respectively).

Conclusions

In a large series of unselected and consecutive patients with Cushing’s disease, transsphenoidal surgery performed by one dedicated experienced neurosurgeon had a reasonably low risk of complications. In particular, despite the higher burden of comorbidities typically associated with hypercortisolism, medical complications are rare and no more frequent than in patients with nonfunctioning pituitary adenoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. C. Steffensen, A.M. Bak, K.Z. Rubeck, J.O. Jorgensen, Epidemiology of cushing’s syndrome. Neuroendocrinology 92(Suppl 1), 1–5 (2010). doi:10.1159/000314297

    Article  CAS  PubMed  Google Scholar 

  2. M. Losa, P. Mortini, S. Dylgjeri, R. Barzaghi, A. Franzin, C. Mandelli, M. Giovanelli, Desmopressin stimulation test before and after pituitary surgery in patients with cushing’s disease. Clin. Endocrinol. 55(1), 61–68 (2001)

    Article  CAS  Google Scholar 

  3. P. Mortini, M. Losa, R. Barzaghi, N. Boari, M. Giovanelli, Results of transsphenoidal surgery in a large series of patients with pituitary Adenoma. Neurosurgery 56(6), 1222–1233 (2005). doi:10.1227/01.neu.0000159647.64275.9d

    Article  PubMed  Google Scholar 

  4. B.M. Biller, A.B. Grossman, P.M. Stewart, S. Melmed, X. Bertagna, J. Bertherat, M. Buchfelder, A. Colao, A.R. Hermus, L.J. Hofland, A. Klibanski, A. Lacroix, J.R. Lindsay, J. Newell-Price, L.K. Nieman, S. Petersenn, N. Sonino, G.K. Stalla, B. Swearingen, M.L. Vance, J.A. Wass, M. Boscaro, Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement. J. Clin Endocrinol. Metab. 93(7), 2454–2462 (2008). doi:10.1210/jc.2007-2734

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. N.A. Tritos, B.M. Biller, B. Swearingen, Management of cushing disease. Nat. Rev. Endocrinol. 7(5), 279–289 (2011). doi:10.1038/nrendo.2011.12

    Article  CAS  PubMed  Google Scholar 

  6. R. Pivonello, M. De Leo, A. Cozzolino, A. Colao, The treatment of cushing’s disease. Endocr. Rev. 36(4), 385–486 (2015). doi:10.1210/er.2013-1048

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. R.R. Lonser, L. Nieman, E.H. Oldfield, Cushing’s disease: pathobiology, diagnosis, and management. J. Neurosurg. 1–14 (2016). 10.3171/2016.1.JNS152119

  8. F.G. Barker 2nd, A. Klibanski, B. Swearingen, Transsphenoidal surgery for pituitary tumors in the United States, 1996–2000: mortality, morbidity, and the effects of hospital and surgeon volume. J. Clin. Endocrinol. Metab. 88(10), 4709–4719 (2003). doi:10.1210/jc.2003-030461

    Article  CAS  PubMed  Google Scholar 

  9. L.R. Barzaghi, M. Losa, M. Giovanelli, P. Mortini, Complications of transsphenoidal surgery in patients with pituitary adenoma: experience at a single centre. Acta. Neurochir. 149(9), 877–886 (2007). doi:10.1007/s00701-007-1244-8

    Article  CAS  PubMed  Google Scholar 

  10. I. Ciric, A. Ragin, C. Baumgartner, D. Pierce, Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery 40(2), 225–237 (1997)

    Article  CAS  PubMed  Google Scholar 

  11. A.N. Mamelak, Pro: endoscopic endonasal transsphenoidal pituitary surgery is superior to microscope-based transsphenoidal surgery. Endocrine 47(2), 409–414 (2014). doi:10.1007/s12020-014-0294-y

    Article  CAS  PubMed  Google Scholar 

  12. P. Mortini, Cons: endoscopic endonasal transsphenoidal pituitary surgery is not superior to microscopic transsphenoidal surgery for pituitary adenomas. Endocrine 47(2), 415–420 (2014). doi:10.1007/s12020-014-0365-0

    Article  CAS  PubMed  Google Scholar 

  13. A.L. Utz, B. Swearingen, B.M. Biller, Pituitary surgery and postoperative management in Cushing’s disease. Endocrinol. Metab. Clin. North. Am. 34(2), 459–478 (2005). doi:10.1016/j.ecl.2005.01.007. xi

    Article  PubMed  Google Scholar 

  14. R. Domi, Cushing’s surgery: role of the anesthesiologist. Indian. J. Endocrinol. Metab. 15(Suppl 4), S322–328 (2011). doi:10.4103/2230-8210.86975

    Article  PubMed  PubMed Central  Google Scholar 

  15. S. Cannavo, E. Messina, A. Albani, F. Ferrau, V. Barresi, S. Priola, F. Esposito, F. Angileri, Clinical management of critically ill patients with cushing’s disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide. Endocrine 52(3), 481–487 (2016). doi:10.1007/s12020-015-0601-2

    Article  CAS  PubMed  Google Scholar 

  16. F. Castinetti, I. Morange, P. Jaquet, B. Conte-Devolx, T. Brue, Ketoconazole revisited: a preoperative or postoperative treatment in cushing’s disease. Eur. J. Endocrinol. 158(1), 91–99 (2008). doi:10.1530/EJE-07-0514

    Article  CAS  PubMed  Google Scholar 

  17. V.A. Preda, J. Sen, N. Karavitaki, A.B. Grossman, Etomidate in the management of hypercortisolaemia in cushing’s syndrome: a review. Eur. J. Endocrinol. 167(2), 137–143 (2012). doi:10.1530/EJE-12-0274

    CAS  PubMed  Google Scholar 

  18. P. Kamenicky, C. Droumaguet, S. Salenave, A. Blanchard, C. Jublanc, J.F. Gautier, S. Brailly-Tabard, S. Leboulleux, M. Schlumberger, E. Baudin, P. Chanson, J. Young, Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent cushing’s syndrome. J. Clin. Endocrinol. Metab. 96(9), 2796–2804 (2011). doi:10.1210/jc.2011-0536

    Article  CAS  PubMed  Google Scholar 

  19. K. McKeage, Pasireotide: a review of its use in cushing’s disease. Drugs 73(6), 563–574 (2013). doi:10.1007/s40265-013-0052-0

    Article  CAS  PubMed  Google Scholar 

  20. M.R. Gadelha, L. Vieira Neto, Efficacy of medical treatment in cushing’s disease: a systematic review. Clin. Endocrinol. 80(1), 1–12 (2014). doi:10.1111/cen.12345

    Article  CAS  Google Scholar 

  21. O.F. van den Bosch, A.M. Stades, P.M. Zelissen, Increased long-term remission after adequate medical cortisol suppression therapy as presurgical treatment in cushing’s disease. Clin. Endocrinol. 80(2), 184–190 (2014). doi:10.1111/cen.12286

    Article  Google Scholar 

  22. M. Losa, C.A. Donofrio, R. Barzaghi, P. Mortini, Presentation and surgical results of incidentally discovered nonfunctioning pituitary adenomas: evidence for a better outcome independently of other patients’ characteristics. Eur. J. Endocrinol. 169(6), 735–742 (2013). doi:10.1530/EJE-13-0515

    Article  CAS  PubMed  Google Scholar 

  23. M. Gemma, C. Tommasino, S. Cozzi, S. Narcisi, P. Mortini, M. Losa, A. Soldarini, Remifentanil provides hemodynamic stability and faster awakening time in transsphenoidal surgery. Anesth. Analg. 94(1), 163–168 (2002)

    CAS  PubMed  Google Scholar 

  24. P. Mortini, R. Barzaghi, M. Losa, N. Boari, M. Giovanelli, Surgical treatment of giant pituitary adenomas: strategies and results in a series of 95 consecutive patients. Neurosurgery 60(6), 993–1004 (2007). doi:10.1227/01.NEU.0000255459.14764.BA

    Article  PubMed  Google Scholar 

  25. M. Ammirati, L. Wei, I. Ciric, Short-term outcome of endoscopic versus microscopic pituitary adenoma surgery: a systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry. 84(8), 843–849 (2013). doi:10.1136/jnnp-2012-303194

    Article  PubMed  Google Scholar 

  26. T.J. Mampalam, J.B. Tyrrell, C.B. Wilson, Transsphenoidal microsurgery for cushing disease. A report of 216 cases. Ann. Intern. Med. 109(6), 487–493 (1988)

    Article  CAS  PubMed  Google Scholar 

  27. D. Bochicchio, M. Losa, M. Buchfelder, Factors influencing the immediate and late outcome of cushing’s disease treated by transsphenoidal surgery: a retrospective study by the European cushing’s disease survey group. J. Clin. Endocrinol. Metab. 80(11), 3114–3120 (1995). doi:10.1210/jcem.80.11.7593411

    CAS  PubMed  Google Scholar 

  28. U.J. Knappe, D.K. Ludecke, Persistent and recurrent hypercortisolism after transsphenoidal surgery for cushing’s disease. Acta. Neurochir. Suppl. 65, 31–34 (1996)

    CAS  PubMed  Google Scholar 

  29. C. Invitti, F. Pecori Giraldi, M. de Martin, F. Cavagnini, Diagnosis and management of Cushing’s syndrome: results of an Italian multicentre study. Study group of the Italian society of endocrinology on the pathophysiology of the hypothalamic-pituitary-adrenal axis. J. Clin. Endocrinol. Metab. 84(2), 440–448 (1999). doi:10.1210/jcem.84.2.5465

    CAS  PubMed  Google Scholar 

  30. G.D. Hammer, J.B. Tyrrell, K.R. Lamborn, C.B. Applebury, E.T. Hannegan, S. Bell, R. Rahl, A. Lu, C.B. Wilson, Transsphenoidal microsurgery for cushing’s disease: initial outcome and long-term results. J. Clin. Endocrinol. Metab. 89(12), 6348–6357 (2004). doi:10.1210/jc.2003-032180

    Article  CAS  PubMed  Google Scholar 

  31. C.G. Patil, D.M. Prevedello, S.P. Lad, M.L. Vance, M.O. Thorner, L. Katznelson, E.R. Laws Jr., Late recurrences of Cushing’s disease after initial successful transsphenoidal surgery. J. Clin. Endocrinol. Metab. 93(2), 358–362 (2008). doi:10.1210/jc.2007-2013

    Article  CAS  PubMed  Google Scholar 

  32. B.M. Hofmann, M. Hlavac, R. Martinez, M. Buchfelder, O.A. Muller, R. Fahlbusch, Long-term results after microsurgery for cushing disease: experience with 426 primary operations over 35 years. J. Neurosurg. 108(1), 9–18 (2008). doi:10.3171/JNS/2008/108/01/0009

    Article  PubMed  Google Scholar 

  33. J. Jagannathan, R. Smith, H.L. DeVroom, A.O. Vortmeyer, C.A. Stratakis, L.K. Nieman, E.H. Oldfield, Outcome of using the histological pseudocapsule as a surgical capsule in Cushing disease. J. Neurosurg. 111(3), 531–539 (2009). doi:10.3171/2008.8.JNS08339

    Article  PubMed  PubMed Central  Google Scholar 

  34. J.R. Lindsay, E.H. Oldfield, C.A. Stratakis, L.K. Nieman, The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing’s disease after transsphenoidal surgery. J. Clin. Endocrinol. Metab. 96(7), 2057–2064 (2011). doi:10.1210/jc.2011-0456

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. J.K. Lambert, L. Goldberg, S. Fayngold, J. Kostadinov, K.D. Post, E.B. Geer, Predictors of mortality and long-term outcomes in treated cushing’s disease: a study of 346 patients. J. Clin. Endocrinol. Metab. 98(3), 1022–1030 (2013). doi:10.1210/jc.2012-2893

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. W.F. Chandler, A.L. Barkan, T. Hollon, A. Sakharova, J. Sack, B. Brahma, D.E. Schteingart, Outcome of transsphenoidal surgery for cushing disease: a single-center experience over 32 years. Neurosurgery 78(2), 216–223 (2016). doi:10.1227/NEU.0000000000001011

    Article  PubMed  Google Scholar 

  37. R.A. Feelders, L.J. Hofland, W.W. de Herder, Medical treatment of cushing’s syndrome: adrenal-blocking drugs and ketaconazole. Neuroendocrinology 92(Suppl 1), 111–115 (2010). doi:10.1159/000314292

    Article  CAS  PubMed  Google Scholar 

  38. P.L. Semple, E.R. Laws Jr., Complications in a contemporary series of patients who underwent transsphenoidal surgery for cushing’s disease. J. Neurosurg. 91(2), 175–179 (1999). doi:10.3171/jns.1999.91.2.0175

    Article  CAS  PubMed  Google Scholar 

  39. P.F. Svider, M.D. Raikundalia, M.J. Pines, S. Baredes, A.J. Folbe, J.K. Liu, J.A. Eloy, Inpatient complications after transsphenoidal surgery in cushing’s versus non-cushing’s disease patients. Ann. Otol. Rhinol. Laryngol. 125(1), 5–11 (2016). doi:10.1177/0003489415595424

    Article  PubMed  Google Scholar 

  40. R.A. Feelders, S.J. Pulgar, A. Kempel, A.M. Pereira, The burden of cushing’s disease: clinical and health-related quality of life aspects. Eur. J. Endocrinol. 167(3), 311–326 (2012). doi:10.1530/EJE-11-1095

    Article  CAS  PubMed  Google Scholar 

  41. R.N. Clayton, D. Raskauskiene, R.C. Reulen, P.W. Jones, Mortality and morbidity in cushing’s disease over 50 years in stoke-on-trent, UK: audit and meta-analysis of literature. J. Clin. Endocrinol. Metab. 96(3), 632–642 (2011). doi:10.1210/jc.2010-1942

    Article  CAS  PubMed  Google Scholar 

  42. S.T. Sharma, L.K. Nieman, R.A. Feelders, Comorbidities in cushing’s disease. Pituitary 18(2), 188–194 (2015). doi:10.1007/s11102-015-0645-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. E. Valassi, A. Santos, M. Yaneva, M. Toth, C.J. Strasburger, P. Chanson, J.A. Wass, O. Chabre, M. Pfeifer, R.A. Feelders, S. Tsagarakis, P.J. Trainer, H. Franz, K. Zopf, S. Zacharieva, S.W. Lamberts, A. Tabarin, S.M. Webb, E.S. Group, The European registry on cushing’s syndrome: 2-year experience. Baseline demographic and clinical characteristics. Eur. J. Endocrinol. 165(3), 383–392 (2011). doi:10.1530/EJE-11-0272

    Article  CAS  PubMed  Google Scholar 

  44. L. Trementino, G. Arnaldi, G. Appolloni, V. Daidone, C. Scaroni, A. Casonato, M. Boscaro, Coagulopathy in cushing’s syndrome. Neuroendocrinology 92(Suppl 1), 55–59 (2010). doi:10.1159/000314349

    Article  CAS  PubMed  Google Scholar 

  45. M. Boscaro, N. Sonino, A. Scarda, L. Barzon, F. Fallo, M.T. Sartori, G.M. Patrassi, A. Girolami, Anticoagulant prophylaxis markedly reduces thromboembolic complications in cushing’s syndrome. J. Clin. Endocrinol. Metab. 87(8), 3662–3666 (2002). doi:10.1210/jcem.87.8.8703

    CAS  PubMed  Google Scholar 

  46. R. van der Pas, F.W. Leebeek, L.J. Hofland, W.W. de Herder, R.A. Feelders, Hypercoagulability in cushing’s syndrome: prevalence, pathogenesis and treatment. Clin. Endocrinol. 78(4), 481–488 (2013). doi:10.1111/cen.12094

    Article  Google Scholar 

  47. R. Fahlbusch, M. Buchfelder, O.A. Muller, Transsphenoidal surgery for Cushing’s disease. J. R. Soc. Med. 79(5), 262–269 (1986)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. I. Ciric, J.C. Zhao, H. Du, J.W. Findling, M.E. Molitch, R.E. Weiss, S. Refetoff, W.D. Kerr, J. Meyer, Transsphenoidal surgery for cushing disease: experience with 136 patients. Neurosurgery 70(1), 70–81 (2012). doi:10.1227/NEU.0b013e31822dda2c

    Article  PubMed  PubMed Central  Google Scholar 

  49. T.R. Smith, M.M. Hulou, K.T. Huang, B. Nery, S.M. de Moura, D.J. Cote, E.R. Laws, Complications after transsphenoidal surgery for patients with cushing’s disease and silent corticotroph adenomas. Neurosurg. Focus. 38(2), E12 (2015). doi:10.3171/2014.10.FOCUS14705

    Article  PubMed  Google Scholar 

  50. D. Wilson, D.L. Jin, T. Wen, J.D. Carmichael, S. Cen, W.J. Mack, G. Zada, Demographic factors, outcomes, and patient access to transsphenoidal surgery for cushing’s disease: analysis of the nationwide inpatient sample from 2002 to 2010. Neurosurg. Focus. 38(2), E2 (2015). doi:10.3171/2014.11.FOCUS14694

    Article  PubMed  Google Scholar 

  51. B.R. Olson, D. Rubino, J. Gumowski, E.H. Oldfield, Isolated hyponatremia after transsphenoidal pituitary surgery. J. Clin. Endocrinol. Metab. 80(1), 85–91 (1995). doi:10.1210/jcem.80.1.7829644

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Dr. I. Snider for his contribution in the analysis of data obtained from the ICAR.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carmine Antonio Donofrio.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Donofrio, C.A., Losa, M., Gemma, M. et al. Safety of transsphenoidal microsurgical approach in patients with an ACTH-secreting pituitary adenoma. Endocrine 58, 303–311 (2017). https://doi.org/10.1007/s12020-016-1214-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-016-1214-0

Keywords

Navigation